Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1983
Inhibition of mitogen-induced proliferation of mouse T and B lymphocytes by bloodstream forms of Trypanosoma cruziJ R Maleckar, F KierszenbaumThe Journal of Parasitology|April 1, 1981
Sarcocystis singaporensis Zaman and Colley, (1975) 1976, Sarcocystis villivilliso sp. n., and Sarcocystis zamani sp. n.: development, morphology, and persistence in the laboratory rat, Rattus norvegicusP C Beaver, J R MaleckarJournal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
The composition of the T cell receptor repertoire in nude miceJ R Maleckar, L A ShermanCancer Treatment Reviews|June 1, 1989
IL-2: a review of current knowledgeR K Oldham, J R Maleckar, J R Yannelli, et al.Clinical Chemistry|August 1, 1989
Tumor-derived activated cells: preliminary laboratory and clinical resultsR K Oldham, J R Maleckar, C S Friddell, et al.Archives of Biochemistry and Biophysics|April 1, 1997
Identification and partial characterization of ectoATPase expressed by immortalized B lymphocytesK E Dombrowski, K A Brewer, J R Maleckar, et al.Breast Cancer Research and Treatment|December 1, 1990
Cultured breast cystosarcoma phylloides cells and applications to patient therapyW M Lewko, R Vaghmar, J R Maleckar, et al.Journal of Immunological Methods|June 12, 1990
Use of anti-CD3 monoclonal antibody in the generation of effector cells from human solid tumors for use in cancer biotherapyJ R Yannelli, D B Crumpacker, R W Good, et al.Journal of the National Cancer Institute|November 1, 1989
Activation and expansion of tumor-derived activated cells for therapeutic useJ R Maleckar, C S Friddell, A Sferruzza, et al.Molecular Biotherapy|June 1, 1991
Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group TrialR K Oldham, R O Dillman, J R Yannelli, et al.Pageof 2